Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sphingomyelin phosphodiesterase 1, acid lysosomal | Starlite/ChEMBL | No references |
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Homo sapiens | RAD52 homolog (S. cerevisiae) | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Candida albicans | dihydrofolate reductase | Starlite/ChEMBL | References |
Homo sapiens | dihydrofolate reductase | Starlite/ChEMBL | References |
Rattus norvegicus | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | dihydrofolate reductase | 187 aa | 202 aa | 29.7 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0786 | 0.467 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0019 | 0.0084 | 0.0152 |
Echinococcus multilocularis | Smad4 | 0.001 | 0.0029 | 0.0007 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0832 | 0.083 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.011 | 0.0107 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0082 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.011 | 0.0025 |
Mycobacterium leprae | DIHYDROFOLATE REDUCTASE DFRA (DHFR) (TETRAHYDROFOLATE DEHYDROGENASE) | 0.1678 | 1 | 1 |
Echinococcus multilocularis | dual specificity | 0.0108 | 0.0615 | 0.0594 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0301 | 0.0301 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.0189 | 0.0168 |
Brugia malayi | thymidylate synthase | 0.0116 | 0.0661 | 0.0658 |
Entamoeba histolytica | hypothetical protein | 0.0119 | 0.0684 | 0.2425 |
Echinococcus granulosus | smad | 0.001 | 0.0029 | 0.0007 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0108 | 0.0615 | 0.1291 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0063 |
Brugia malayi | MH2 domain containing protein | 0.001 | 0.0029 | 0.0026 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.041 | 0.041 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0786 | 0.467 | 1 |
Trypanosoma brucei | unspecified product | 0.0016 | 0.0066 | 0.0113 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.0611 | 0.0609 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0301 | 0.0298 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.001 | 0.0029 | 0.0029 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0034 | 0.0013 |
Leishmania major | DNA polymerase eta, putative | 0.0023 | 0.011 | 0.0206 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.011 | 0.328 |
Schistosoma mansoni | smad | 0.001 | 0.0029 | 0.0029 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0786 | 0.467 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0832 | 0.083 |
Schistosoma mansoni | dihydrofolate reductase | 0.1678 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0301 | 0.0298 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 0.0567 | 0.1928 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.011 | 0.0088 |
Echinococcus multilocularis | smad | 0.001 | 0.0029 | 0.0007 |
Brugia malayi | MH1 domain containing protein | 0.001 | 0.0029 | 0.0026 |
Echinococcus granulosus | dihydrofolate reductase | 0.1678 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0301 | 0.0279 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0108 | 0.0615 | 0.0615 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0011 | 0.0034 | 0.0031 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0084 |
Brugia malayi | Protein kinase domain containing protein | 0.0108 | 0.0615 | 0.0612 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.011 | 0.328 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.0363 | 0.0751 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0301 | 0.0301 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.001 | 0.0029 | 0.0007 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.011 | 0.0096 |
Trypanosoma brucei | unspecified product | 0.0016 | 0.0066 | 0.0113 |
Loa Loa (eye worm) | histone methyltransferase | 0.0011 | 0.0034 | 0.0032 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.011 | 0.039 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0063 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.011 | 0.0206 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0055 | 0.0299 | 0.0216 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.011 | 0.0088 |
Schistosoma mansoni | DNA polymerase eta | 0.0023 | 0.011 | 0.011 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0029 | 0.0029 |
Entamoeba histolytica | Acid sphingomyelinase-like phosphodiesterase, putative | 0.01 | 0.0567 | 0.1928 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 0.1678 | 1 | 1 |
Echinococcus granulosus | Smad4 | 0.001 | 0.0029 | 0.0007 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.001 | 0.0029 | 0.0007 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0084 | 0.0152 |
Mycobacterium ulcerans | thymidylate synthase | 0.0116 | 0.0661 | 0.0648 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0034 | 0.0013 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Leishmania major | serine/threonine-protein kinase, putative,protein kinase, putative | 0.0108 | 0.0615 | 0.1291 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0301 | 0.0279 |
Leishmania major | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0023 | 0.011 | 0.0107 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.011 | 0.0088 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0189 | 0.0189 |
Trypanosoma cruzi | CMGC/DYRK protein kinase, putative | 0.0108 | 0.0615 | 0.1291 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0833 | 0.4953 | 0.4942 |
Brugia malayi | Dihydrofolate reductase | 0.1678 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0108 | 0.0615 | 0.213 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.011 | 0.0025 |
Loa Loa (eye worm) | Smad1 | 0.001 | 0.0029 | 0.0026 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0786 | 0.467 | 1 |
Schistosoma mansoni | DNA polymerase IV / kappa | 0.0007 | 0.0014 | 0.0014 |
Entamoeba histolytica | protein kinase, putative | 0.0108 | 0.0615 | 0.213 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0189 | 0.0189 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.001 | 0.0029 | 0.0026 |
Loa Loa (eye worm) | hypothetical protein | 0.0007 | 0.0014 | 0.0011 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.0189 | 0.0168 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0084 | 0.0152 |
Echinococcus multilocularis | dihydrofolate reductase | 0.1678 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.011 | 0.0206 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0301 | 0.0279 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0108 | 0.0615 | 0.213 |
Chlamydia trachomatis | dihydrofolate reductase | 0.1678 | 1 | 0.5 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0786 | 0.467 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0063 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0116 | 0.0661 | 0.0661 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 0.4953 | 0.4942 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0029 | 0.0029 |
Loa Loa (eye worm) | CMGC/DYRK/DYRK1 protein kinase | 0.0108 | 0.0615 | 0.0612 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0116 | 0.0661 | 0.0581 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0152 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.001 | 0.0029 | 0.0007 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0063 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0019 | 0.0084 | 0.0152 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0301 | 0.0279 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0019 | 0.0084 | 0.0152 |
Brugia malayi | hypothetical protein | 0.0055 | 0.0299 | 0.0296 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.011 | 0.0206 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.011 | 0.0206 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0022 | 0.0022 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.011 | 0.0107 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0023 | 0.011 | 0.0206 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.011 | 0.0107 |
Echinococcus multilocularis | thymidylate synthase | 0.0116 | 0.0661 | 0.064 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0029 | 0.0029 |
Brugia malayi | MH1 domain containing protein | 0.001 | 0.0029 | 0.0026 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Brugia malayi | Smad1 | 0.001 | 0.0029 | 0.0026 |
Echinococcus multilocularis | dna polymerase eta | 0.0023 | 0.011 | 0.0088 |
Loa Loa (eye worm) | thymidylate synthase | 0.0116 | 0.0661 | 0.0658 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 0.4953 | 0.4953 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0832 | 0.083 |
Schistosoma mansoni | Smad4 | 0.001 | 0.0029 | 0.0029 |
Entamoeba histolytica | Rad52/22 family double-strand break repair protein, putative | 0.0119 | 0.0684 | 0.2425 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.0178 | 0.0175 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.011 | 0.0096 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.1678 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0066 | 0.0113 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0567 | 0.0564 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0055 | 0.0299 | 0.0613 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0786 | 0.467 | 1 |
Brugia malayi | MH2 domain containing protein | 0.001 | 0.0029 | 0.0026 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0066 | 0.0113 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.011 | 0.0088 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.0611 | 0.0609 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0152 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.0084 | 0.0063 |
Giardia lamblia | DNA repair protein RAD52 | 0.042 | 0.248 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0108 | 0.0615 | 0.213 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.011 | 0.011 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0084 | 0.0152 |
Mycobacterium ulcerans | dihydrofolate reductase DfrA | 0.1678 | 1 | 1 |
Entamoeba histolytica | DNA repair and recombination protein RAD52, putative | 0.042 | 0.248 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0019 | 0.0084 | 0.0152 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0023 | 0.011 | 0.0206 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.001 | 0.0029 | 0.0026 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0063 |
Echinococcus granulosus | thymidylate synthase | 0.0116 | 0.0661 | 0.064 |
Echinococcus granulosus | dual specificity | 0.0108 | 0.0615 | 0.0594 |
Brugia malayi | polk-prov protein | 0.0007 | 0.0014 | 0.0011 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.001 | 0.0029 | 0.0007 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0023 | 0.011 | 0.0206 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0301 | 0.0301 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0.0299 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.0178 | 0.0178 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0066 | 0.0113 |
Brugia malayi | isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0082 |
Brugia malayi | Isocitrate dehydrogenase | 0.0019 | 0.0084 | 0.0082 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.011 | 0.0206 |
Onchocerca volvulus | 0.0116 | 0.0661 | 1 | |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.0178 | 0.0175 |
Echinococcus granulosus | dna polymerase eta | 0.0023 | 0.011 | 0.0088 |
Trypanosoma brucei | CMGC/DYRK protein kinase, putative | 0.0108 | 0.0615 | 0.1291 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.011 | 0.011 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (binding) | = 5.506 uM | PUBCHEM_BIOASSAY: MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442] | ChEMBL. | No reference |
AC50 (functional) | = 11.97 uM | PubChem BioAssay. FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
AC50 (functional) | 38.56 uM | PubChem BioAssay. Identification of Inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
EC50 (functional) | = 4.797 um | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to BJeLR RAS-Dependent Fibroblast. (Class of assay: confirmatory) [Related pubchem assays: 1674 (Project Summary), 1554 (Primary HTS)] | ChEMBL. | No reference |
EC50 (functional) | > 38 um | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT-LT-ST RAS-Independent Fibroblast. (Class of assay: confirmatory) [Related pubchem assays: 1674 (Project Summary), 1554 (Primary HTS)] | ChEMBL. | No reference |
EC50 (functional) | = 111.702 um | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Compounds Cytotoxic to BJ-TERT RAS-Independent Fibroblast. (Class of assay: confirmatory) [Related pubchem assays: 1674 (Project Summary), 1554 (Primary HTS)] | ChEMBL. | No reference |
EC50 (functional) | > 133.3 uM | PUBCHEM_BIOASSAY: Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1554, AID1674] | ChEMBL. | No reference |
GI50 (functional) | = 3.34 uM | Growth inhibition of human MDA-MB-468 cells after 72 hrs by MTT assay | ChEMBL. | 24163729 |
IC50 (functional) | = 1450 nM | Activity of the compound was evaluated against HCT-8 tumor cells | ChEMBL. | 8632413 |
IC50 (functional) | = 1450 nM | Activity of the compound was evaluated against HCT-8 tumor cells | ChEMBL. | 8632413 |
Inhibition (functional) | = 0 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 0.22 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 2.25 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 2.46 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 8 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 58 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 88 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 2.84 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Ki (binding) | = 1 nM | Competitive inhibition of human recombinant DHFR preincubated for 2 mins followed by substrate addition in presence of dihydrofolate | ChEMBL. | 25937878 |
Ki (binding) | = 23 nM | Inhibition of Dihydrofolate reductase enzyme from Candida albicans | ChEMBL. | 8632413 |
Ki (binding) | = 23 nM | Inhibition of Dihydrofolate reductase enzyme from Candida albicans | ChEMBL. | 8632413 |
Ki (binding) | = 1000 nM | Inhibition of human recombinant Dihydrofolate reductase enzyme | ChEMBL. | 8632413 |
Ki (binding) | = 1000 nM | Inhibition of human recombinant Dihydrofolate reductase enzyme | ChEMBL. | 8632413 |
MIC (functional) | = 0.8 ug ml-1 | Minimum inhibitory concentration evaluated against Candida albicans | ChEMBL. | 8632413 |
MIC (functional) | = 0.8 ug ml-1 | Minimum inhibitory concentration evaluated against Candida albicans | ChEMBL. | 8632413 |
Percent growth inhibition (functional) | = -1 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 8 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 58 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 88 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
Potency (functional) | = 0.3981 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 1.2589 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 1.4125 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 1.6511 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 2.2387 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 3.6964 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 5.8048 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom's syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM))] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) | ChEMBL. | No reference |
XC50 (functional) | = 5.97 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 1.08044 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 8632413 | |
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.